ew mechanistic research on insulin resistance-related ovarian dysfunction in patients with polycystic ovary syndrome and obesity

Gachon University Gil Medical Center0 个研究点目标入组 115 人开始时间: 待定最近更新: 2021年6月24日

试验速览

暂无简介。

•Women aged 19 years or older and under 45 years old
•-Those who fall under one of the following three
•1) Patients with PCOS or obesity with amenorrhea or oligomenorrhea, who are expected to undergo obesity metabolic surgery
•2) Patients with PCOS or obesity with amenorrhea or oligomenrrhea menstruation and undergoing life therapy treatment or observation
•3) Normal control group (female reproductive function is normal and body mass index 18.5 to 24.9)
•-Or those who collect eggs for infertility

•-Women under the age of 19 and over 45
•-Those who are administering hormones that affect female reproductive function other than for the purpose of collecting oocytes or have been administered within the last 6 months
•-Diabetic patients taking antidiabetic drugs or insulin injection treatment
•-Those who are administering oral contraceptives or have been given oral contraceptives within the last 6 months
•-Those taking antihypertensive drugs
•-Those who are administering anti-obesity injections or oral drugs for the treatment of obesity, or have administered them within the last 3 months
•-Those who do not perform a pregnancy test or are unsure whether they are pregnant
•-If the average alcohol consumption per day for the past 2 years exceeded 20g (approximately 2 glasses of soju) and lasted for 3 months or more
•-Liver disease of other causes other than non-alcoholic fatty liver disease
•-History of taking drugs that cause secondary fatty liver within the last 1 year (corticosteroids, tamoxifen, amiodarone, methotrexate, etc.)
•-Patients with suspected female reproductive dysfunction due to causes other than obesity or PCOS
•-Those who are judged to be inappropriate to participate in this study due to other systemic diseases

发起方